Literature DB >> 15278789

Neuromuscular effects of pipecuronium during sevoflurane anesthesia compared with isoflurane and enflurane anesthesia.

Y Nakao1, M Ohno, M Imai, O Kemmotsu.   

Abstract

We evaluated the neuromuscular effects of pipecuronium during anesthesia with equipotent concentrations of either sevoflurane, isoflurane or enflurane. Twenty-seven patients scheduled for minor elective otolaryngeal or plastic surgery were studied and randomly assigned to 3 groups, one group per anesthetic agent. Anesthesia was induced with thiamylal 5 mg.kg(-1) and the trachea was intubated with succinylcholine 1 mg.kg(-1), then anesthesia was maintained with 60% nitrous oxide in oxygen and sevolfurane, isoflurane or enflurane, depending on the group. Neuromuscular blocking effects were monitored by recording the electromyographic activity of the adductor pollicis muscle from supramaximal stimulation of the ulnar nerve at 10-s intervals. Pipecuronium 40 microg.kg(-1) was administered when electromyographic activity had reached a stable state, 30 min after succinylcholine administration. The maximum effect (% block of control) and clinical duration (time to 25% recovery) of pipecuronium were 99.1 +/- 1.4% and 63.7 +/- 14.7 min (mean +/- S.D.) for sevoflurane, 99.0 +/- 2.0% and 60.9 +/- 20.5 min for isoflurane, and 98.0 +/- 2.5% and 62.8 +/- 28.7 min for enflurane, respectively. There were no significant differences in these values between the anesthetics. Cardiovascular stimulant effects were not observed in any of the groups. We conclude that the effect of pipecuronium under seveflurane anesthesia is similar to that under isoflurane and enflurane anesthesia.

Entities:  

Year:  1993        PMID: 15278789     DOI: 10.1007/s0054030070405

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  16 in total

1.  Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages.

Authors:  W C Stevens; W M Dolan; R T Gibbons; A White; E I Eger; R D Miller; R H DeJong; R M Elashoff
Journal:  Anesthesiology       Date:  1975-02       Impact factor: 7.892

2.  Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium.

Authors:  M Y Dubois; N W Fleming; D E Lea
Journal:  Anesth Analg       Date:  1991-03       Impact factor: 5.108

3.  Modification of the action of pancuronium by succinylcholine and halothane.

Authors:  R L Katz
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

4.  [A clinical and experimental study on potentiation with sevoflurane of neuromuscular blocking effects of vecuronium and pancuronium].

Authors:  T Itagaki; K Tai; N Katsumata; H Suzuki
Journal:  Masui       Date:  1988-08

5.  Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children.

Authors:  J F Pittet; E Tassonyi; D R Morel; G Gemperle; M Richter; J C Rouge
Journal:  Anesthesiology       Date:  1989-08       Impact factor: 7.892

6.  Comparative clinical study of pipecurium bromide and pancuronium bromide.

Authors:  M Boros; J Szenohradszky; G Marosi; I Tóth
Journal:  Arzneimittelforschung       Date:  1980

7.  Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.

Authors:  M Abdulatif; M Naguib
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

8.  Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.

Authors:  E Kárpáti; K Biró
Journal:  Arzneimittelforschung       Date:  1980

9.  Neuromuscular and cardiovascular effects of pipecuronium.

Authors:  F F Foldes; H Nagashima; H D Nguyen; D Duncalf; P L Goldiner
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

10.  The influence of succinylcholine on the duration of pancuronium neuromuscular blockade.

Authors:  L F Walts; W D Rusin
Journal:  Anesth Analg       Date:  1977 Jan-Feb       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.